Oridonin could down‐regulate TGF‐β and p‐smad2/3 protein expression and up‐regulate Smad4 protein expression, thereby reducing downstream Smad2/3 activity, activating the Smad4 protein and inhibiting the proliferation of cancer cells.78 This evidence concerns the gene SMAD2 and cancer.